Masashi Iwamoto

1.9k total citations
20 papers, 1.3k citations indexed

About

Masashi Iwamoto is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Masashi Iwamoto has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 18 papers in Hepatology and 4 papers in Infectious Diseases. Recurrent topics in Masashi Iwamoto's work include Hepatitis B Virus Studies (18 papers), Hepatitis C virus research (18 papers) and Liver Disease Diagnosis and Treatment (5 papers). Masashi Iwamoto is often cited by papers focused on Hepatitis B Virus Studies (18 papers), Hepatitis C virus research (18 papers) and Liver Disease Diagnosis and Treatment (5 papers). Masashi Iwamoto collaborates with scholars based in Japan, France and United States. Masashi Iwamoto's co-authors include Koichi Watashi, Takaji Wakita, Hideki Aizaki, Ryosuke Suzuki, Senko Tsukuda, Yasuhito Tanaka, Hiroyuki Kusuhara, Masashi Mizokami, Masaya Sugiyama and Akihide Ryo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Hepatology.

In The Last Decade

Masashi Iwamoto

19 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masashi Iwamoto Japan 16 1.1k 818 244 183 178 20 1.3k
Senko Tsukuda Japan 17 1.0k 0.9× 747 0.9× 354 1.5× 172 0.9× 180 1.0× 34 1.4k
Tianlun Zhou United States 17 907 0.8× 675 0.8× 415 1.7× 234 1.3× 119 0.7× 33 1.3k
Dongping Xu China 22 1.4k 1.3× 1.2k 1.5× 152 0.6× 219 1.2× 79 0.4× 66 1.7k
Olaf Weber Germany 18 733 0.7× 412 0.5× 191 0.8× 240 1.3× 172 1.0× 34 1.3k
Christophe Ramière France 18 478 0.4× 518 0.6× 200 0.8× 305 1.7× 62 0.3× 33 1.0k
Asako Murayama Japan 18 882 0.8× 975 1.2× 514 2.1× 150 0.8× 45 0.3× 50 1.6k
Kaku Goto Japan 21 596 0.5× 752 0.9× 391 1.6× 145 0.8× 227 1.3× 41 1.4k
Yutaka Amako United States 11 338 0.3× 384 0.5× 251 1.0× 75 0.4× 77 0.4× 13 781
Mohsan Saeed United States 19 402 0.4× 434 0.5× 322 1.3× 451 2.5× 38 0.2× 44 1.1k
Xuanyong Lu United States 16 473 0.4× 319 0.4× 246 1.0× 145 0.8× 42 0.2× 26 781

Countries citing papers authored by Masashi Iwamoto

Since Specialization
Citations

This map shows the geographic impact of Masashi Iwamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Iwamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Iwamoto more than expected).

Fields of papers citing papers by Masashi Iwamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Iwamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Iwamoto. The network helps show where Masashi Iwamoto may publish in the future.

Co-authorship network of co-authors of Masashi Iwamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Iwamoto. A scholar is included among the top collaborators of Masashi Iwamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Iwamoto. Masashi Iwamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stappenbeck, Frank, Hirofumi Ohashi, Masashi Iwamoto, et al.. (2023). Selective inhibition of hepatitis B virus internalization by oxysterol derivatives. Biochemical and Biophysical Research Communications. 675. 139–145. 3 indexed citations
2.
Kobayashi, Chisa, Yoshihiro Watanabe, Tomoyasu Hirose, et al.. (2022). Fungal Secondary Metabolite Exophillic Acid Selectively Inhibits the Entry of Hepatitis B and D Viruses. Viruses. 14(4). 764–764. 17 indexed citations
3.
Iwamoto, Masashi, Junna Kawasaki, Shohei Kojima, et al.. (2021). Identification of novel avian and mammalian deltaviruses provides new insights into deltavirus evolution. Virus Evolution. 7(1). veab003–veab003. 22 indexed citations
4.
Yoshio, Sachiyo, Hironari Kawai, Taiji Yamazoe, et al.. (2020). Impact of Immune Reconstitution-Induced Hepatic Flare on Hepatitis B Surface Antigen Loss in Hepatitis B Virus/Human Immunodeficiency Virus-1 Coinfected Patients. The Journal of Infectious Diseases. 223(12). 2080–2089. 19 indexed citations
5.
Iwamoto, Masashi, Wakana Saso, Kazane Nishioka, et al.. (2020). The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network. Journal of Biological Chemistry. 295(3). 800–807. 50 indexed citations
6.
Iwamoto, Masashi, Wakana Saso, Kazane Nishioka, et al.. (2019). The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network. Journal of Biological Chemistry. 295(3). 800–807. 45 indexed citations
7.
Yamada, N., Asako Murayama, Masaaki Shiina, et al.. (2019). Anti‐viral effects of interferon‐λ3 on hepatitis B virus infection in cell culture. Hepatology Research. 50(3). 283–291. 7 indexed citations
8.
Takeuchi, Toshifumi, Kazane Nishioka, Masashi Iwamoto, et al.. (2019). Synthesis of nucleotide analogues, EFdA, EdA and EdAP, and the effect of EdAP on hepatitis B virus replication. Bioscience Biotechnology and Biochemistry. 84(2). 217–227. 1 indexed citations
10.
Iwamoto, Masashi, Wakana Saso, Ryuichi Sugiyama, et al.. (2019). Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization. Proceedings of the National Academy of Sciences. 116(17). 8487–8492. 187 indexed citations
11.
Takeuchi, Junko S., Kento Fukano, Masashi Iwamoto, et al.. (2018). A Single Adaptive Mutation in Sodium Taurocholate Cotransporting Polypeptide Induced by Hepadnaviruses Determines Virus Species Specificity. Journal of Virology. 93(5). 25 indexed citations
12.
Iwamoto, Masashi, Dawei Cai, Masaya Sugiyama, et al.. (2017). Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication. Scientific Reports. 7(1). 10620–10620. 41 indexed citations
13.
Takemoto, Kenji, Shinji Kamisuki, Syo Nakajima, et al.. (2016). Anti-hepatitis C Virus Natural Product from a Fungus, Penicillium herquei. Journal of Natural Products. 79(2). 442–446. 33 indexed citations
14.
Watashi, Koichi, Kento Fukano, Michael Peel, et al.. (2016). Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity. Journal of Hepatology. 66(4). 685–692. 94 indexed citations
15.
Tsukuda, Senko, Koichi Watashi, Masanori Isogawa, et al.. (2016). A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins. Hepatology. 65(4). 1104–1116. 65 indexed citations
16.
Watashi, Koichi, Shinji Kamisuki, Masashi Iwamoto, et al.. (2015). A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide. Journal of Virology. 89(23). 11945–11953. 68 indexed citations
17.
Tsukuda, Senko, Koichi Watashi, Masashi Iwamoto, et al.. (2014). Dysregulation of Retinoic Acid Receptor Diminishes Hepatocyte Permissiveness to Hepatitis B Virus Infection through Modulation of Sodium Taurocholate Cotransporting Polypeptide (NTCP) Expression. Journal of Biological Chemistry. 290(9). 5673–5684. 52 indexed citations
18.
19.
Iwamoto, Masashi, Koichi Watashi, Senko Tsukuda, et al.. (2013). Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. Biochemical and Biophysical Research Communications. 443(3). 808–813. 249 indexed citations
20.
Watashi, Koichi, Guoxin Liang, Masashi Iwamoto, et al.. (2013). Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID). Journal of Biological Chemistry. 288(44). 31715–31727. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026